Researchers performed a systematic literature review and meta-analysis. They searched PubMed, CINAHL, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects and Embase and identified studies evaluating discontinuation of contact precautions for multidrug-resistant organisms. They found 14 studies that met inclusion criteria.
Of the 14, six studies discontinued contact precautions for both MRSA and VRE; three for MRSA only; two for VRE only; and two for extended-spectrum β-lactamase–producing Escherichia coli; and one for Clostridium difficile infection.
The researchers found a trend toward reduction of MRSA infection after contact precautions were discontinued. Additionally, they found a statistically significant reduction in VRE infection.
More articles on healthcare quality:
3 ways hospitals can reduce unnecessary lab testing
50%+ of nursing schools do not have reporting tool for student errors, near misses
5 Qs with Lucile Packard Children’s CMO on their new patient-centered hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
